Medical Cannabis – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Sun, 15 Oct 2023 02:34:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Medical Cannabis – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Anxiety severity and prescription medication utilization in first-time medical marijuana users https://www.cannabisclinicians.org/2023/10/14/anxiety-severity-and-prescription-medication-utilization-in-first-time-medical-marijuana-users/ Sun, 15 Oct 2023 02:34:43 +0000 https://www.cannabisclinicians.org/?p=29435 Anxiety and post-traumatic stress disorder (PTSD) are qualifying psychiatric conditions for medical marijuana (MM) treatment in Pennsylvania. This study examined baseline prevalence and changes in prescription anxiety medication use three months following MM treatment initiation among individuals with these qualifying conditions. The study sample was comprised of 108 adults with anxiety or PTSD as a referring condition; they were enrolled in a longitudinal study evaluating biopsychosocial outcomes in new MM patients. Consenting participants completed an assessment battery at baseline and Month 3 (n = 94, 87 % follow-up rate) that included a measure of anxiety severity and questions about current anxiety medication prescription and desired (baseline) and actual (Month 3) reductions in medication use.

The post Anxiety severity and prescription medication utilization in first-time medical marijuana users appeared first on Society of Cannabis Clinicians.

]]> Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases https://www.cannabisclinicians.org/2023/09/20/medical-cannabis-alleviates-chronic-neuropathic-pain-effectively-and-sustainably-without-severe-adverse-effect-a-retrospective-study-on-99-cases/ Thu, 21 Sep 2023 00:24:25 +0000 https://www.cannabisclinicians.org/?p=29246 Medical cannabis may provide a treatment option for chronic neuropathic pain. However, empirical disease-specific data are scarce. This is a retrospective observational study including 99 patients with chronic neuropathic pain. These patients received medical cannabis by means of inhaling dried flowers with tetrahydrocannabinol content of <12–22% at a maximal daily dose of 0.15–1 g. Up to six follow-ups were carried out at intervals of 4–6 weeks. Pain severity, sleep disturbance, general improvement, side effects, and therapy tolerance at the follow-up consultations were assessed in interviews and compared with the baseline data using non-parametric Wilcoxon signed-rank test.

The post Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases appeared first on Society of Cannabis Clinicians.

]]> Quality of Life in Patients Receiving Medical Cannabis https://www.cannabisclinicians.org/2023/09/06/quality-of-life-in-patients-receiving-medical-cannabis/ Wed, 06 Sep 2023 11:52:14 +0000 https://www.cannabisclinicians.org/?p=29151 Medical cannabis has been used to relieve the symptoms of people with various chronic diseases. Despite of this, it has been stigmatized, even after its legalization in many countries. The purpose of this study was to investigate the quality of life of patients receiving medical cannabis. One hundred patients receiving medical cannabis were given (a) a socio-demographic and clinical questionnaire, and (b) the SF-36 Health Survey scale for assessing quality of life.

The post Quality of Life in Patients Receiving Medical Cannabis appeared first on Society of Cannabis Clinicians.

]]> A single-center real-life study on the use of medical cannabis in patients with dystonia https://www.cannabisclinicians.org/2023/07/29/a-single-center-real-life-study-on-the-use-of-medical-cannabis-in-patients-with-dystonia/ Sat, 29 Jul 2023 17:21:31 +0000 https://www.cannabisclinicians.org/?p=28989 While cannabis-based medicine is being commonly used in patients with movement disorders, there is a scarcity of publications regarding the effect of cannabis on dystonia. We aimed to describe medical cannabis use in patients with dystonia and related pain. We employed a structured interview to obtain data on the cannabis treatment regimen, perception of effectiveness and side effect profile. Eligible participants were patients diagnosed with dystonia from the movement disorders unit at the Tel-Aviv Medical Center who had used licensed medical cannabis between January 2019 and January 2021.

The post A single-center real-life study on the use of medical cannabis in patients with dystonia appeared first on Society of Cannabis Clinicians.

]]> Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry https://www.cannabisclinicians.org/2023/05/27/assessment-of-clinical-outcomes-in-patients-with-fibromyalgia-analysis-from-the-uk-medical-cannabis-registry/ Sun, 28 May 2023 00:54:44 +0000 https://www.cannabisclinicians.org/?p=28703 There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze changes in health-related quality of life and incidence of adverse events of those prescribed cannabis-based medicinal products (CBMPs) for fibromyalgia.  Patients treated with CBMPs for a minimum of 1 month were identified from the UK Medical Cannabis Registry. Primary outcomes were changes in validated patient-reported outcome measures (PROMs). A p-value of <.050 was deemed statistically significant.

The post Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry appeared first on Society of Cannabis Clinicians.

]]> Medical Cannabis in the Treatment of Parkinson’s Disease https://www.cannabisclinicians.org/2023/04/22/medical-cannabis-in-the-treatment-of-parkinsons-disease/ Sat, 22 Apr 2023 18:24:24 +0000 https://www.cannabisclinicians.org/?p=28427 Medical cannabis (MC) has recently garnered interest as a potential treatment for neurologic diseases, including Parkinson’s disease (PD). A retrospective chart review was conducted to explore the impact of MC on the symptomatic treatment of patients with PD. Patients with PD treated with MC in the normal course of clinical practice were included (n = 69). Data collected from patient charts included MC ratio/formulation changes, PD symptom changes after initiation of MC, and adverse events (AEs) from MC use. Information regarding changes in concomitant medications after MC initiation, including opioids, benzodiazepines, muscle relaxants, and PD medications, was also collected.

The post Medical Cannabis in the Treatment of Parkinson’s Disease appeared first on Society of Cannabis Clinicians.

]]> Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment https://www.cannabisclinicians.org/2022/12/16/increased-white-matter-coherence-following-three-and-six-months-of-medical-cannabis-treatment/ Sat, 17 Dec 2022 02:40:57 +0000 https://www.cannabisclinicians.org/?p=27313 Previous studies have demonstrated abnormal white matter (WM) microstructure in recreational cannabis consumers; however, the long-term impact of medical cannabis (MC) use on WM coherence is unknown. Accordingly, this study assessed the longitudinal impact of MC treatment on WM coherence. Given results from preclinical studies, we hypothesized that MC treatment would be associated with increased fractional anisotropy (FA) and reduced mean diffusivity (MD).

The post Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment appeared first on Society of Cannabis Clinicians.

]]> Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment https://www.cannabisclinicians.org/2022/11/25/increased-white-matter-coherence-following-three-and-six-months-of-medical-cannabis-treatment-2/ Fri, 25 Nov 2022 23:44:53 +0000 https://www.cannabisclinicians.org/?p=27209 Previous studies have demonstrated abnormal white matter (WM) microstructure in recreational cannabis consumers; however, the long-term impact of medical cannabis (MC) use on WM coherence is unknown. Accordingly, this study assessed the longitudinal impact of MC treatment on WM coherence. Given results from preclinical studies, we hypothesized that MC treatment would be associated with increased frac- tional anisotropy (FA) and reduced mean diffusivity (MD).

The post Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment appeared first on Society of Cannabis Clinicians.

]]> Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients https://www.cannabisclinicians.org/2022/10/29/cannabinoids-for-behavioral-symptoms-in-severe-dementia-safety-and-feasibility-in-a-long-term-pilot-observational-study-in-nineteen-patients/ Sat, 29 Oct 2022 18:24:05 +0000 https://www.cannabisclinicians.org/?p=27057 The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest an interest in the use of medical cannabis, but long-term data are lacking. The objective of this study was to investigate the feasibility and long-term safety of administering tetrahydrocannabinol/cannabidiol (THC/CBD) treatment as an additional drug to a poly medicated population with severe dementia, evaluate clinical improvements, and collect information on the pharmacokinetics of cannabinoids and possible drug–drug interactions.

The post Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients appeared first on Society of Cannabis Clinicians.

]]> SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!” https://www.cannabisclinicians.org/event/scc-csequence-presents-journal-club-cannabis-consumption-used-by-cancer-patients-during-immunotherapy-correlates-with-poor-clinical-outcome/ Fri, 06 May 2022 16:00:00 +0000 https://www.cannabisclinicians.org/?post_type=tribe_events&p=26395 Friday, May 6, 2022 at 9am PDT / 12pm EDT Research Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!”...

The post SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!” appeared first on Society of Cannabis Clinicians.

]]>